BeStock  
Stocks › Biotechnology › DNLI

Denali Therapeutics DNLI

US equityMarket cap rank #2440Biotechnology
$18.45 +$0.25 (+1.37%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $18.45 0.00%
Open$17.97
Prev close$18.20
Day range$17.92 – $18.85
Volume2.63M
Market cap$2.96B
P/E (TTM)–
Dividend yield–

DNLI Stock News

Headlines matching Denali Therapeutics or the DNLI ticker, most recent first.

  • A Quick Look at Today's Ratings for Denali Therapeutics(DNLI.US), With a Forecast Between $31 to $42Market news · 8 Aug 2026 · Direct mention
  • A Quick Look at Today's Ratings for Denali Therapeutics(DNLI.US), With a Forecast Between $31 to $41Market news · 7 Aug 2026 · Direct mention
  • B. Riley Securities Maintains Denali Therapeutics(DNLI.US) With Buy Rating, Raises Target Price to $35 PositiveMarket news · 25 Aug 2026 · Direct mention
  • J.P. Morgan Maintains Denali Therapeutics(DNLI.US) With Buy Rating, Maintains Target Price $29Market news · 11 Aug 2026 · Direct mention
  • Morgan Stanley Maintains Denali Therapeutics(DNLI.US) With Buy Rating, Raises Target Price to $36 PositiveMarket news · 23 Jul 2026 · Direct mention
  • Deutsche Bank Maintains Denali Therapeutics(DNLI.US) With Buy Rating, Raises Target Price to $35 PositiveMarket news · 16 Jul 2026 · Direct mention
  • BofA Securities Maintains Denali Therapeutics(DNLI.US) With Buy Rating, Announces Target Price $31Market news · 15 Jul 2026 · Direct mention
  • J.P. Morgan Maintains Denali Therapeutics(DNLI.US) With Buy Rating, Raises Target Price to $29 PositiveMarket news · 13 Jul 2026 · Direct mention
  • H.C. Wainwright Maintains Denali Therapeutics(DNLI.US) With Buy Rating, Maintains Target Price $42Market news · 13 Jul 2026 · Direct mention
  • Wedbush Maintains Denali Therapeutics(DNLI.US) With Buy Rating, Raises Target Price to $26 PositiveMarket news · 13 Jul 2026 · Direct mention
  • UBS Maintains Denali Therapeutics(DNLI.US) With Buy Rating, Maintains Target Price $25Market news · 16 Jun 2026 · Direct mention
  • William Blair Maintains Denali Therapeutics(DNLI.US) With Buy RatingMarket news · 9 May 2026 · Direct mention
  • Analysts Offer Insights on Healthcare Companies: Agilon Health (AGL), CG Oncology, Inc. (CGON) and Denali Therapeutics (DNLI)TipRanks · 9 May 2026 · Direct mention
  • TD Cowen Maintains Denali Therapeutics(DNLI.US) With Buy RatingMarket news · 9 May 2026 · Direct mention
  • Wedbush Maintains Denali Therapeutics(DNLI.US) With Buy Rating, Cuts Target Price to $23 NegativeMarket news · 8 May 2026 · Direct mention

Discussion

No comments yet — be the first to weigh in on DNLI.

Sign in to join the discussion.

Scroll to Top